The MLKL inhibitor, necrosulfonaminde [134], significantly inhibited docetaxel‐mediated necroptosis in MDA‐MB‐231 breast cancer cells transfected with BAD, validating the role of BAD in the modulation of necroptosis [133]. This evidence concerns the gene BAD and breast cancer.